http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2239632-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-541 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-503 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-541 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-503 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025 |
| filingDate | 2000-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cffb8da3603c05452ba3ef4d44195027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d6b91b05f3a73580738bc909841d6de http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2e821b133177206a4cec78a7938c0bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_765821d2c4675d1ad523091d30be9247 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63bc9fe9f752a99ca865db4a85c0ec9c |
| publicationDate | 2005-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2239632-T3 |
| titleOfInvention | PIRIDAZINO-QUINOLINA DERIVATIVE AND METHOD FOR THE TREATMENT OF PAIN. |
| abstract | It has now been discovered that a certain compound, which shows the property of binding to the glycine site of the NMDA receptor, has utility for pain relief, and particularly for the relief of neuropathic pain. Therefore, in one aspect, the invention provides a compound, 7-chloro-4-hydroxy-2- (2-chloro-4-methylphenyl) -1, 2, 5, 10-tetrahydropyridazino [4,5-b] quinolin-1, 10-dione, according to structural diagram I In another aspect, the invention provides a method for treating pain using a compound according to structural diagram I, the method comprising administering an effective amount of the pain relieving compound. In another embodiment, the method comprises administering an effective, pain-relieving amount of the compound according to structural diagram I, in the form of a pharmaceutical composition comprising a compound according to structural diagram I as active ingredient, together with one or more additives. pharmaceutically acceptable. In a further embodiment, the method comprises binding the compound of the invention to the glycine site of the NMDA receptor of a warm-blooded animal, such as a human being, to beneficially inhibit the activity of the NMDA receptor. Another aspect of the invention is a method for obtaining the compound according to structural diagram I. Still other aspects of the invention are pharmaceutical compositions containing the compound according to structural diagram I, and the use of the compound according to structural diagram I for the preparation. of medications and pharmaceutical compositions. |
| priorityDate | 1999-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 157.